
SentiSense
Ctrl+K
Quick tip: Press
to search stocks
P
PFE
Pfizer Inc.
$27.05
+0.44 (+1.65%)
Summary
Stories
News
Metrics
Fundamentals
Drag to measure
Stock Reports
Upgrade to access stock reports prepared by our team with the help of AI.
What's Included
Curated Bull & Bear Case Analysis
Data-Driven Investment Perspectives
Quantified Risks & Catalysts
Expert-Curated Financial Research
Company Profile
Symbol
PFE
Market Cap
$153.81B
IPO Date
Jun 22, 1951
CEO
Albert Bourla
Employees
75,000
Sector
--
Industry
PHARMACEUTICAL PREPARATIONS
Country
United States
Exchange
--
Pfizer is one of the world's largest pharmaceutical firms, with annual sales of roughly $60 billion. While it historically sold many types of healthcare products and chemicals, now prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13 and cardiology drugs Vyndaqel and Eliquis. Pfizer sells these products globally, with international sales representing 40% of total sales. Within international sales, emerging markets are a major contributor.
Read MoreSimilar Stocks
MRNA
Moderna Inc.
$52.52
-2.43%
MRK
Merck & Co., Inc.
$115.79
-0.24%
JNJ
Johnson & Johnson
$240.40
+0.32%